Use our pre-submission checklist
Avoid common mistakes on your manuscript.
Correction to: Journal of Neuro-Oncology https://doi.org/10.1007/s11060-019-03194-z
The last author's first name was truncated in the initial online publication. The original article has been corrected.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Jaeckle, K.A., Anderson, S.K., Twohy, E.L. et al. Correction to: Phase I-II trial of imatinib mesylate (Gleevec; STI571) in treatment of recurrent oligodendroglioma and mixed oligoastrocytoma. North central cancer treatment group study N0272 (ALLIANCE/NCCTG). J Neurooncol 143, 583 (2019). https://doi.org/10.1007/s11060-019-03201-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11060-019-03201-3